Guangzhou FineImmune Biotechnology Co., LTD.
5 clinical trials · Sponsor
◉ Watch Guangzhou FineImmune Biotechnology Co., LTD.
| Record | Firm | Date |
|---|---|---|
| An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma (NCT07493044) | Guangzhou FineImmune Biotechnology Co., LTD. | 2026-03-27 |
| An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors (NCT06942143) | Guangzhou FineImmune Biotechnology Co., LTD. | 2025-05-22 |
| A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors (NCT06716619) | Guangzhou FineImmune Biotechnology Co., LTD. | 2025-02-13 |
| Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors (NCT06302062) | Guangzhou FineImmune Biotechnology Co., LTD. | 2023-06-06 |
| Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors (NCT03891706) | Guangzhou FineImmune Biotechnology Co., LTD. | 2019-01-08 |
Track Guangzhou FineImmune Biotechnology Co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.